Table 3.
Variable | Vitamin D group (n = 29) | Placebo group (n = 30) | P |
---|---|---|---|
NIHSS | |||
Baseline | 10.16 ± 4.70 | 12.08 ± 4.14 | 0.125 |
After | 5.60 ± 4.16 | 6.60 ± 3.30 | 0.313 |
P | 0.001 | 0.001 | |
MRS | |||
Baseline | 3.10 ± 0.84 | 3.53 ± 1.10 | 0.121 |
After | 1.60 ± 1.16 | 2.33 ± 1.15 | 0.014 |
P | 0.001 | 0.001 | |
MMSE | |||
Baseline | 19.73 ± 5.65 | 20.26 ± 6.18 | 0.807 |
After | 24.40 ± 3.64 | 23.26 ± 4.69 | 0.466 |
P | 0.001 | 0.013 |
Data are presented as mean ± standard deviation (SD)
NIHSS: National Institute of Health Stroke Scale; MRS: Modified Rankin Scale; MMSE: Mini-Mental State Examination